July 30, 2021 - ROSEN LOGO.jpg
NATIONALLY RANKED ROSEN LAW FIRM Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation – ALT
February 19, 2024 16:53 ET | The Rosen Law Firm PA
NEW YORK, Feb. 19, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Altimmune,...
GLP-1 receptor agonist-based compounds are the most common drug class in late stage clinical trials
Airfinity launches world’s first obesity data and analytics platform
January 24, 2024 04:57 ET | Airfinity
London, England, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Today, Airfinity is launching the world’s first data and analytics platform dedicated to the breakthrough obesity treatments market.  ...
Oprah Obesity Ozempic
PhysicalMind Offers 80Bites Program to Weight Watchers; Announces 80Bites E-Book release “Oprah Obesity Ozempic”
January 22, 2024 12:00 ET | PhysicalMind Institute
PhysicalMind Institute, a pioneering Pilates & Posture & BodyMind Exercise company, announces why it is offering to gift WW its 80Bites program.
Oprah Obesity Ozempic
PhysicalMind Offers 80Bites Program to Weight Watchers; Announces 80Bites E-Book release “Oprah Obesity Ozempic”
January 20, 2024 14:29 ET | PhysicalMind Institute
PhysicalMind Institute, a pioneering Pilates & Posture & BodyMind Exercise company, announces why it is offering to gift WW its 80Bites program.
Telegenixx.png
Workplace Weight Loss & Wellness Program Unveiled
October 04, 2023 13:27 ET | Telegenixx
Telegenix's New Program Enables Employers to Provide Access to Pharma-Assisted Weight Loss at a Cost of $299 per Month, 70% Below the Industry Average
mobileapp
80Bites Mobile App Release
August 14, 2023 09:03 ET | PhysicalMind Institute
NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- PhysicalMind Institute, the company that helped bring Pilates to worldwide fame, announces the release of the 80Bites mobile application which helps an...
Global Glucagon-like Peptide 1 (GLP-1) Market
Global Glucagon-like Peptide 1 (GLP-1) Market Analysis Report 2023: Potential Clinical Application of GLP-1 Receptor Agonists For the Treatment of NASH Gaining Momentum
January 30, 2023 06:23 ET | Research and Markets
Dublin, Jan. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Glucagon-like Peptide 1 (GLP-1) Market: Analysis By Product (Trulicity, Ozempic, Victoza, Rybelsus and Other GLP 1 Products), By Route of...
ST. PETE MEDICAL GROUP
Over 20 Million Suffer From Peripheral Neuropathy, St. Pete Medical Group Aims to Help
December 14, 2022 12:30 ET | St. Pete Medical Group
ST. PETERSBURG, Fla., Dec. 14, 2022 (GLOBE NEWSWIRE) -- St. Pete Medical Group and Clearwater Medical Group were featured on 10 Tampa Bay's Great Day Live. Dr. Alex Spinoso announced their mission...
Canadian pharmacy logo
Investigational 2.0mg Semaglutide Dose Promoted for Type 2 Diabetics With Higher A1c Score
September 07, 2022 15:00 ET | Canada Pharmacy
VICTORIA, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Novo Nordisk introduced Ozempic to the market in 2017, giving Type 2 diabetics a different option when it comes to their injections...